In contrast, serum NGAL was shown to be elevated in all stages of the myeloma spectrum (MGUS, smoldering MM (SMM), and MM), whereas serum cystatin C was increased in symptomatic MM patients [50]. This evidence concerns the gene LCN2 and Miyoshi myopathy.